Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals

被引:25
|
作者
Shafer, RW [1 ]
Warford, A [1 ]
Winters, MA [1 ]
Gonzales, MJ [1 ]
机构
[1] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA
关键词
HIV-1; protease; reverse transcriptase;
D O I
10.1016/S0166-0934(00)00144-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The reproducibility of population-based human immunodeficiency virus type 1 (HIV-I) protease and reverse transcriptase (RT) sequencing was assessed using replicate aliquots of cryopreserved plasma samples obtained from seven heavily treated HIV-1-infected individuals. The sequence of each sample replicate was compared with the consensus sequence for that sample and 99.4% of 35128 amino acids were found to be concordant with the sample consensus. Partial discordances were present at 0.5% of positions and complete discordances were present at <0.1% of positions. To assess the reproducibility at detecting mutations (defined here as differences from the subtype B consensus sequence), the proportion of sequences having a mutation when at least two sequences from that sample had the same mutation were examined. There was a median of 13 protease and 18 RT mutations per sample for a total of 3126 mutations; 95% of these mutations were detected. However, sequencing of multiple clones from two samples demonstrated that those mutations present in a minority of clones were often not detected by population-based sequencing. These results suggest that HIV-I protease and RT sequencing of circulating plasma virus is highly reproducible but that the sensitivity at detecting mutations may be low if those mutations are present as minor variants. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:143 / 153
页数:11
相关论文
共 50 条
  • [1] Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins
    Cherry, E
    Liang, C
    Rong, LW
    Quan, YD
    Inouye, P
    Li, XG
    Morin, N
    Kotler, N
    Wainberg, MA
    JOURNAL OF MOLECULAR BIOLOGY, 1998, 284 (01) : 43 - 56
  • [2] Bent pseudoknots and novel RNA inhibitors of type 1 human immunodeficiency virus (HIV-1) reverse transcriptase
    Burke, DH
    Scates, L
    Andrews, K
    Gold, L
    JOURNAL OF MOLECULAR BIOLOGY, 1996, 264 (04) : 650 - 666
  • [3] Metabolic characterization of plasma samples in HIV-1-infected individuals
    Zhang, Ting
    Sun, Jianping
    Du, Haiwei
    Su, Haoxiang
    Zhang, Yonghong
    Jin, Qi
    FUTURE MICROBIOLOGY, 2018, 13 (09) : 985 - 996
  • [4] HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance
    Shafer, Robert W.
    Rhee, Soo-Yon
    Pillay, Deenan
    Miller, Veronica
    Sandstrom, Paul
    Schapiro, Jonathan M.
    Kuritzkes, Daniel R.
    Bennett, Diane
    AIDS, 2007, 21 (02) : 215 - 223
  • [5] In vitro inhibition of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase by gold(III) porphyrins
    Sun, RWY
    Yu, WY
    Sun, HZ
    Che, CM
    CHEMBIOCHEM, 2004, 5 (09) : 1293 - 1298
  • [6] MUTATIONAL ANALYSIS OF THE FINGERS AND PALM SUBDOMAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REVERSE-TRANSCRIPTASE
    BOYER, PL
    FERRIS, AL
    CLARK, P
    WHITMER, J
    FRANK, P
    TANTILLO, C
    ARNOLD, E
    HUGHES, SH
    JOURNAL OF MOLECULAR BIOLOGY, 1994, 243 (03) : 472 - 483
  • [7] Characterization of human immunodeficiency virus type 1 (HIV-1) containing mutations in the nucleocapsid protein at a putative HIV-1 protease cleavage site
    Thomas, James A.
    Shulenin, Sergey
    Coren, Lori V.
    Bosche, William J.
    Gagliardi, Tracy D.
    Gorelick, Robert J.
    Oroszlan, Stephen
    VIROLOGY, 2006, 354 (02) : 261 - 270
  • [8] Eradication of Human Immunodeficiency Virus Type-1 (HIV-1)-Infected Cells
    Duzgunes, Nejat
    Konopka, Krystyna
    PHARMACEUTICS, 2019, 11 (06)
  • [9] Human immunodeficiency virus type 1 reverse transcriptase
    Hottiger, M
    Hubscher, U
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1996, 377 (02): : 97 - 120
  • [10] The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults
    Mackie, Nicola E.
    Dunn, David T.
    Dolling, David
    Garvey, Lucy
    Harrison, Linda
    Fearnhill, Esther
    Tilston, Peter
    Sabin, Caroline
    Geretti, Anna M.
    AIDS, 2013, 27 (14) : 2245 - 2253